---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-023445"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2022-08-18T23:59:59+00:00"
generated_at: "2026-06-23T22:48:51.828822+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma raises $203K via convertible notes with dilutive conversion terms

## Summary
- Entered convertible note agreements with GS Capital ($93K principal, net $88K after $5K OID) and ONE44 ($110K principal, net $100K after $10K OID).
- Notes bear interest at 8% (GS) and 10% (ONE44), mature in one year (Aug 2023).
- Conversion price for GS note fixed at $0.0028/share, dropping to $0.0013 if stock trades under $0.002 for 5 days; ONE44 at 65% of lowest bid.
- Prepayment premiums range from 110%-130% (GS) and 120%-135% (ONE44) of face value plus interest, within 180 days.
- Proceeds used for general working capital; notes are convertible into common stock with 4.99% beneficial ownership cap.

## SEC filing metadata
- accession: 0001493152-22-023445
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2022-08-18T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315222023445/0001493152-22-023445-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315222023445/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-023445
- JSON: https://secwatch.observer/filing/0001493152-22-023445.json
- Plain text: https://secwatch.observer/filing/0001493152-22-023445.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.